MARKET EYE-India's Cipla surges to record high on earnings

Tue Nov 6, 2012 10:23am IST

Related Topics

Stocks

   

* Shares in Cipla gains as much as 4.06 percent to a
record high after the drug maker reported a bigger-than-expected
62 percent surge in July-September net profit. 
* Despite the surge in share prices, Citigroup says on Tuesday
it remains cautious, saying the earnings surprise were mainly
driven by the generic version of anti-depressant drug Lexapro,
whose exclusivity would tail off in the second half of the
fiscal year.
* Cipla had earlier given a revenue guidance of up to 12 percent
 for the current fiscal year, but Citigroup says the company
management has now revised its topline growth to 15 percent or
above in FY13.     
* Citigroup adds positives such as better product mix and upside
from a weaker rupee appeared factored into estimates
and valuations. 
* The bank raised its target price to 390 rupees from 360
rupees, but retained its 'neutral' rating.
* Cipla shares advanced 2.8 percent to 390.90 rupees as of 0437
GMT

 (manoj.dharra@thomsonreuters.com)
FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Pricing Controls

REUTERS SHOWCASE

India-China Relations

India-China Relations

India says to defend China border after standoff ahead of Xi visit.  Full Article 

Importing Iron Ore

Importing Iron Ore

As mining curbs bite, India offers market to glut-hit iron ore.  Full Article 

Drug Approval

Drug Approval

Epirus, Ranbaxy win India approval for arthritis drug copy.  Full Article 

Rajan Speaks

Rajan Speaks

RBI chief Rajan says limiting reliance on foreign debt.  Full Article 

Debt & Equity Deal

Debt & Equity Deal

KKR to lend $175 million to GMR Infrastructure - source.  Full Article 

Preparing for IPO

Preparing for IPO

Alibaba boosts IPO as demand strengthens.  Full Article 

India-Vietnam Ties

India-Vietnam Ties

India tightens Vietnam defence, oil ties ahead of China Xi's visit.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage